SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 67.71 |
Enterprise Value ($M) | -9.89 |
Book Value ($M) | 26.53 |
Book Value / Share | 0.64 |
Price / Book | 2.55 |
NCAV ($M) | 17.45 |
NCAV / Share | 0.42 |
Price / NCAV | 3.88 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.93 |
Return on Assets (ROA) | -0.56 |
Return on Equity (ROE) | -1.01 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.06 |
Current Ratio | 5.06 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 80.47 |
Assets | 89.55 |
Liabilities | 63.02 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 14.92 |
Operating Income | -88.73 |
Net Income | -86.88 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -81.18 |
Cash from Investing | 72.41 |
Cash from Financing | 62.18 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | AbbVie Biotechnology Ltd | 6.80 | ||
13D/A | HealthCap VII, L.P. | 8.40 | 0.00 | |
13G/A | Vanguard Group Inc | 3.89 | ||
13G/A | Longview Innovation Corp. | 6.70 | -6.29 | |
13D/A | Trustees Of The University Of Pennsylvania | 3.10 | -42.64 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
12,604 | 40,475 | 31.14 | |
25,199 | 91,213 | 27.63 | |
7,197 | 36,728 | 19.60 | |
21,413 | 25,482 | 84.03 | |
33,989 | 35,362 | 96.12 | |
(click for more detail) |
Similar Companies | |
---|---|
BTMD – biote Corp. | CADL – Candel Therapeutics, Inc. |
CARA – Cara Therapeutics, Inc. | CGTX – Cognition Therapeutics, Inc. |
CHRS – Coherus BioSciences, Inc. |
Financial data and stock pages provided by
Fintel.io